Mode
Text Size
Log in / Sign up
N/A Completed N=50

Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI

Source: ClinicalTrials.gov NCT03943160 ↗
Enrolled (actual)
50
Serious AEs
4.0%
Results posted
Mar 2021
Primary outcomePrimary: Procedural Success: — 49 Participants

Summary

The objective of this study is to evaluate acute clinical results of orbital atherectomy (OA) via radial artery access, including complication rates and cost effectiveness.

Outcome Measures

OutcomeResultp-value
PRIMARY
Procedural Success:
49
SECONDARY
Treatment Success:
49

Eligibility Criteria

Inclusion Criteria

  • Subject is ≥ 18 years
  • Subject is willing and able to sign the IRB-approved informed consent form (ICF)
  • Subject presents with a Rutherford Classification of 2 to 5
  • Subject has a positive Allen's Test
  • Subject to undergo peripheral angiography and/or PVI via TRA approach per physician discretion

Index Procedure Inclusion Criteria:

  • Physician obtains successful radial artery access (Note: snuffbox access is allowed)
  • Target lesion appropriate (i.e. location/morphology) for OA treatment via TRA within target area
  • OAS use attempted (defined as ViperWire introduced into the body)

Exclusion Criteria

  • Subject has no palpable radial artery on the planned access arm
  • Subject has a previous failed radial access attempt on planned access arm
  • Subject has a dialysis fistula on planned access arm
  • Subject has a known subclavian stenosis or occlusion
  • Subject has a previous subclavian stent or previous subclavian intervention
  • Subject has a shunt in the radial artery on the planned access arm
  • Subject has evidence of osteomyelitis
  • Subject is currently participating in an investigational drug or device study
  • Subject is pregnant within the study period

Index Procedure Exclusion Criteria

  • Physician unable to obtain radial artery access
  • Physician determines TRA is not acceptable due to patient anatomy, lesion characteristics, and/or disease severity
  • OAS use not attempted (defined as ViperWire introduced into the body)

Prior to insertion of ViperWire:

  • Femoral access is obtained
  • Unsuccessful peripheral intervention
  • A reportable adverse event has occurred
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03943160). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search